Following a gift from Brown trustee Giammaria Giuliani P’28 and Sabrina Giuliani P’28, Brown’s RNA center will be named the ...

SanegeneBio is responsible for discovering and identifying optimised RNAi molecules for each programme through its LEAD ...

Kevin Fitzgerald, Alnylam Pharmaceuticals’ chief scientific officer, reveals the hard times that led to RNAi success, and what it takes to pave new roads in biotech.

IBI3016 demonstrates sustained and potent AGT mRNA suppression with preliminary evidence of antihypertensive efficacy after single-dose subcutaneous administration.

Detailed price information for Benitec Biopharma Ltd ADR (BNTC-Q) from The Globe and Mail including charting and trades.

The company's annualized recurring revenue run rate jumped 30% year over year in Q3 to $2 billion. Its gross payment volume ...

CGT is rapidly transforming the landscape of modern medicine, driving breakthroughs from laboratory research into real-world clinical applications. From genome editing to in vivo and ex vivo cell ...

Fast Track Designation was granted for BB-301 following U.S. Food and Drug Administration (FDA) review of positive interim clinical study ...

Tuna are one of the ocean’s most important commercial fish, providing food for millions of people. Once endangered from overfishing, this species has been helped by sustainable fishing quotas.

Continued advancement toward Phase 2/3 clinical trial initiation, on track for the first half of 2026New preclinical data demonstrated SIL204’s ...

Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, presented highlights of Phase 1 clinical data for RN0361, ...

The vast deep-tech sector has far-reaching roots in Ireland. Here are eight start-ups in the sector making waves in the country and abroad.